title: Asthma severity and atopy: how clear is the relationship?
abstract: BACKGROUND
  The relationship between asthma severity and atopy is complex. Many studies have failed to show significant relationships between clinical severity or lung function and markers of atopic sensitisation.
  
  
  OBJECTIVE
  To determine whether increasing asthma severity is related to atopic sensitisation in a population of children with asthma.
  
  
  METHODS
  A total of 400 children (7-18 years) with asthma were recruited as part of a multicentre study of the genetics of asthma. Detailed phenotypic data were collected on all participants. Associations between measures of asthma severity and atopic sensitisation were sought using multilevel models allowing variation at the individual and family level.
  
  
  RESULTS
  Children recruited to the study had a range of asthma severities, with just over a third having mild persistent asthma. The logarithm of total serum IgE was associated with increased asthma severity score, decreased FEV1, increased airways obstruction, risk of hospital admission, and inhaled steroid use. Increasing skin prick test reactivity to a panel of seven aeroallergens was associated with increased risk of hospital admission, use of an inhaled steroid, and airways obstruction. The results remained highly significant after corrections for age, gender, and birth order.
  
  
  CONCLUSIONS
  In children with asthma, increasing atopy is associated with increasing asthma severity. However, the relationships between asthma severity and skin prick tests, and asthma severity and total serum IgE values, appear subtly different.
authors.affiliation: Department of Child Health, Derbyshire Children's Hospital, Mickleover, Derby, UK.
authors.forename: W D
authors.initials: WD
authors.lastname: Carroll
authors.forename: W
authors.initials: W
authors.lastname: Lenney
authors.forename: F
authors.initials: F
authors.lastname: Child
authors.forename: R C
authors.initials: RC
authors.lastname: Strange
authors.forename: P W
authors.initials: PW
authors.lastname: Jones
authors.forename: M K
authors.initials: MK
authors.lastname: Whyte
authors.forename: R A
authors.initials: RA
authors.lastname: Primhak
authors.forename: A A
authors.initials: AA
authors.lastname: Fryer
mesh_terms: D000293:Adolescent; D000402:Airway Obstruction; D001249:Asthma / Q000097:blood / Q000276:immunology* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D002908:Chronic Disease; D005260:Female; D005541:Forced Expiratory Volume; D006760:Hospitalization; D006801:Humans; D006967:Hypersensitivity / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D007073:Immunoglobulin E / Q000097:blood; D008168:Lung / Q000503:physiopathology; D008297:Male; D018570:Risk Assessment; D012307:Risk Factors; D012882:Skin Tests
chemical_list: D001993:Bronchodilator Agents; D007073:Immunoglobulin E